{
  "meta": {
    "title": "36_Heart_Failure_Heart_Blocks",
    "url": "https://brainandscalpel.vercel.app/36-heart-failure-heart-blocks-4a10a414.html",
    "scrapedAt": "2025-11-30T06:57:15.220Z"
  },
  "questions": [
    {
      "id": 96653,
      "choices": [
        {
          "id": 228659,
          "text": "Narcotic overdose"
        },
        {
          "id": 228660,
          "text": "Congestive heart failure"
        },
        {
          "id": 228661,
          "text": "Myocardial infarction"
        },
        {
          "id": 228662,
          "text": "Cardiogenic shock"
        }
      ],
      "text": "A patient comes with sudden respiratory distress. On examination, bilateral basal crepts are present over chest suggestive of pulmonary edema. Alveolar wedge pressure is normal. The likely cause is-",
      "unique_key": "Q7619975",
      "question_audio": null,
      "question_video": null,
      "map_id": 34214654,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (A) Narcotic overdose. In the scenario presented, the patient shows signs of acute respiratory distress with bilateral basal crepitations (suggesting pulmonary edema). However, the key detail is that the alveolar wedge pressure is normal, which rules out heart failure or fluid overload due to cardiac causes. Narcotic overdose, especially opioids, can lead to respiratory depression and pulmonary edema, even in the absence of cardiac dysfunction. Opioids affect the respiratory centers in the brain, leading to hypoventilation, and this can result in pulmonary edema due to a combination of respiratory depression, hypoxia, and altered fluid dynamics in the lungs. Since the alveolar wedge pressure is normal, this points away from a cardiogenic cause like heart failure or myocardial infarction, making narcotic overdose the most likely explanation. B. Congestive heart failure: This condition usually causes pulmonary edema, but in congestive heart failure, the alveolar wedge pressure would typically be elevated due to increased pulmonary venous pressure. The normal alveolar wedge pressure in this patient rules out congestive heart failure. C. Myocardial infarction: Myocardial infarction can lead to pulmonary edema if it results in significant left ventricular dysfunction, but again, this would typically present with an elevated alveolar wedge pressure due to impaired cardiac output and increased pulmonary venous pressure. The normal wedge pressure here suggests that the cause is not cardiac in nature. D. Cardiogenic shock: Cardiogenic shock results from severe heart failure, leading to inadequate tissue perfusion and pulmonary edema, often with a raised alveolar wedge pressure. The normal alveolar wedge pressure in this patient eliminates cardiogenic shock as the cause of the pulmonary edema.",
      "correct_choice_id": 228659,
      "solution_audio": null,
      "solution_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/13715541700624947/13715541700624947.m3u8",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/13715541700624947/13715541700624947.m3u8",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 96654,
      "choices": [
        {
          "id": 228663,
          "text": "Brain Natriuretic Peptide (BNP)"
        },
        {
          "id": 228664,
          "text": "Atrial Natriuretic Peptide (ANP)"
        },
        {
          "id": 228665,
          "text": "Endothelin-1 (ET-1)"
        },
        {
          "id": 228666,
          "text": "Adrenomedullin"
        }
      ],
      "text": "Assays of which of the following biomarkers is most commonly used in the diagnosis of Heart failure",
      "unique_key": "Q4794292",
      "question_audio": null,
      "question_video": null,
      "map_id": 34021266,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (A) Brain Natriuretic Peptide (BNP). Brain Natriuretic Peptide (BNP) is the most commonly used biomarker for the diagnosis and management of heart failure. BNP is a hormone released by the ventricles in response to increased pressure and volume overload, which are hallmark features of heart failure. Elevated levels of BNP in the blood correlate with the severity of heart failure and are widely used in clinical practice to differentiate heart failure from other conditions that may cause similar symptoms (such as pulmonary edema or shortness of breath). BNP levels are particularly useful in diagnosing acute heart failure and can also help in assessing prognosis. B. Atrial Natriuretic Peptide (ANP): ANP is another natriuretic peptide, but it is mainly released from the atria of the heart in response to atrial stretch. Although it is involved in fluid regulation, its use in the diagnosis of heart failure is less common than BNP. While ANP levels may be elevated in heart failure, BNP is more specific and reliable for clinical diagnosis and management. C. Endothelin-1 (ET-1): Endothelin-1 is a potent vasoconstrictor involved in vascular tone regulation and the pathophysiology of heart failure. However, it is not routinely used as a biomarker for diagnosing heart failure. While ET-1 levels may be elevated in heart failure, it is not as clinically useful or specific as BNP in making a diagnosis. D. Adrenomedullin: Adrenomedullin is a peptide involved in vasodilation and the regulation of blood pressure. Although it has been studied as a potential marker for heart failure, it is not as commonly used in clinical practice as BNP. Its role in heart failure diagnosis is not as established as BNP, making it less useful for routine clinical assessment.",
      "correct_choice_id": 228663,
      "solution_audio": null,
      "solution_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/34827171700624975/34827171700624975.m3u8",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/34827171700624975/34827171700624975.m3u8",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 96655,
      "choices": [
        {
          "id": 228667,
          "text": "Digoxin"
        },
        {
          "id": 228668,
          "text": "Morphine"
        },
        {
          "id": 228669,
          "text": "Furosemide"
        },
        {
          "id": 228670,
          "text": "Positive Pressure Ventilation"
        }
      ],
      "text": "All of the following are used in the initial management of acute life threatening cardiogenic pulmonary edema, except:",
      "unique_key": "Q1654798",
      "question_audio": null,
      "question_video": null,
      "map_id": 34704928,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (A) Digoxin. Digoxin is not typically used in the initial management of acute life-threatening cardiogenic pulmonary edema. While digoxin can be used in the long-term management of heart failure, it does not provide immediate relief in acute pulmonary edema. In fact, digoxin can have negative effects in some cases of acute decompensated heart failure, such as contributing to arrhythmias, especially in the setting of electrolyte imbalances or renal dysfunction. The initial treatment for acute cardiogenic pulmonary edema focuses on reducing the pulmonary congestion and improving oxygenation, not on enhancing myocardial contractility with digoxin. B. Morphine: Morphine is commonly used in the initial management of acute cardiogenic pulmonary edema. It acts as an anxiolytic, reducing the patient's anxiety, which can decrease the sympathetic response and the resultant cardiac workload. Additionally, morphine has mild vasodilatory properties, which help reduce preload and afterload, thereby decreasing pulmonary congestion and improving oxygenation. C. Furosemide: Furosemide, a loop diuretic, is a cornerstone in the treatment of acute cardiogenic pulmonary edema. It helps reduce fluid overload by promoting diuresis, which alleviates the pulmonary congestion and improves gas exchange. Rapid administration of furosemide can help decrease the severity of the edema and improve the patient's respiratory status. D. Positive Pressure Ventilation: Positive pressure ventilation, such as with CPAP or BiPAP, is an essential part of the initial management of acute cardiogenic pulmonary edema. It helps to decrease the work of breathing, improve oxygenation, and reduce the preload and afterload by increasing intrathoracic pressure. This reduces the pulmonary congestion and helps stabilize the patient while other treatments are being initiated.",
      "correct_choice_id": 228667,
      "solution_audio": null,
      "solution_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/29918941700624986/29918941700624986.m3u8",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/29918941700624986/29918941700624986.m3u8",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 96656,
      "choices": [
        {
          "id": 228671,
          "text": "They should be initiated at the effective doses"
        },
        {
          "id": 228672,
          "text": "The should be gradually increased over weeks"
        },
        {
          "id": 228673,
          "text": "Special precautions should be taken NYHA class IV"
        },
        {
          "id": 228674,
          "text": "Carvedilol and Metoprolol are the preferred drugs"
        }
      ],
      "text": "All of the following are true about starting beta-blocker therapy in cases of CHF, Except",
      "unique_key": "Q2935663",
      "question_audio": null,
      "question_video": null,
      "map_id": 34504737,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (A) They should be initiated at the effective doses. When starting beta-blocker therapy in cases of chronic heart failure (CHF), it is not recommended to initiate the treatment at the \"effective doses\" right away. Instead, beta-blockers should be started at low doses and then gradually increased over weeks to the target doses. This is because beta-blockers can initially worsen symptoms of heart failure as they reduce heart rate and contractility, which may temporarily worsen cardiac output. Starting at a low dose and titrating up allows the heart to gradually adapt to the medication, minimizing the risk of exacerbating heart failure symptoms. B. They should be gradually increased over weeks: This statement is true. Beta-blockers should be gradually titrated upwards to the effective doses over several weeks. This slow escalation allows the patient’s heart to adjust to the medication and helps prevent acute decompensation. C. Special precautions should be taken in NYHA class III & IV: This is also true. For patients with more severe heart failure (NYHA class III and IV), extra caution should be taken when initiating beta-blockers. These patients are at higher risk of adverse effects, such as worsening heart failure, due to their compromised cardiac function. However, beta-blockers are still indicated for these patients, but they should be carefully monitored, and the doses should be titrated slowly. D. Carvedilol and Metoprolol are the preferred drugs: This statement is correct. Carvedilol and Metoprolol (specifically Metoprolol succinate, the extended-release formulation) are beta-blockers that have been proven to improve outcomes in CHF. These drugs have specific benefits in heart failure, including reducing mortality, hospitalizations, and improving symptoms. They are commonly used as first-line therapy.",
      "correct_choice_id": 228671,
      "solution_audio": null,
      "solution_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/8330671700624998/8330671700624998.m3u8",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/8330671700624998/8330671700624998.m3u8",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 96657,
      "choices": [
        {
          "id": 228675,
          "text": "ACE + Beta Blocker"
        },
        {
          "id": 228676,
          "text": "ACE-I + Diuretic"
        },
        {
          "id": 228677,
          "text": "ACE-I + ARB"
        },
        {
          "id": 228678,
          "text": "ACE-I + CCB"
        }
      ],
      "text": "Treatment of choice for patients with Congestive Heart Failure and an ejection fraction of < 40 percent is:",
      "unique_key": "Q6347869",
      "question_audio": null,
      "question_video": null,
      "map_id": 34524270,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (A) ACE + Beta Blocker. In patients with Congestive Heart Failure (CHF) and an ejection fraction (EF) of less than 40%, the treatment of choice involves a combination of Angiotensin-Converting Enzyme Inhibitors (ACE inhibitors) and Beta-blockers. ACE inhibitors help to reduce afterload and preload by blocking the effects of angiotensin II, thus improving cardiac output and reducing symptoms of heart failure. Beta-blockers, on the other hand, help by reducing heart rate and preventing excessive sympathetic stimulation, which is harmful in heart failure. The combination of these two classes of drugs has been shown to reduce mortality, improve symptoms, and enhance quality of life in patients with reduced EF heart failure. B. ACE-I + Diuretic: While ACE inhibitors and diuretics are both important in the management of heart failure, the combination of ACE-I and diuretics alone is not the treatment of choice for patients with a reduced ejection fraction of less than 40%. Diuretics help manage fluid overload and symptoms of congestion but do not address the underlying mechanisms contributing to heart failure in these patients. Diuretics can improve symptoms but are not sufficient to improve long-term outcomes or survival. C. ACE-I + ARB: An ACE inhibitor combined with an Angiotensin Receptor Blocker (ARB) may be used in certain patients, especially if they are intolerant to ACE inhibitors due to side effects like cough. However, dual blockade of the renin-angiotensin system with both ACE inhibitors and ARBs is generally avoided unless absolutely necessary due to the risk of renal dysfunction, hyperkalemia, and hypotension. Current guidelines recommend ACE inhibitors as first-line therapy, and ARBs are typically reserved for cases where ACE inhibitors are not tolerated. D. ACE-I + CCB: Calcium Channel Blockers (CCBs) are generally not recommended for patients with heart failure with reduced ejection fraction (HFrEF). While CCBs may be useful in other cardiac conditions, such as hypertension or angina, they are not beneficial in the setting of heart failure and can even worsen outcomes. They can reduce myocardial contractility and should be avoided in most cases of HFrEF. The combination of ACE-I and a CCB is not standard therapy for heart failure.",
      "correct_choice_id": 228675,
      "solution_audio": null,
      "solution_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/11092311707309249/11092311707309249.m3u8",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/11092311707309249/11092311707309249.m3u8",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 96658,
      "choices": [
        {
          "id": 228679,
          "text": "Decreases potassium efflux"
        },
        {
          "id": 228680,
          "text": "Increases the rate of IF or “Funny” sodium channels"
        },
        {
          "id": 228681,
          "text": "Prolongs phase-2 calcium entry"
        },
        {
          "id": 228682,
          "text": "Increases the velocity in Purkinje fibers"
        }
      ],
      "text": "A 30 year old female presented with episodes of lightheadedness, fainting episodes and weakness for last 2-3 months and symptoms are more for last 2 days. On examination pulse rate is 42/minute, BP-80/60 mmHg, chest is clear, CVS-LVS3 is auscultated. ECG done in the emergency shows the following findings. You gave IV atropine and her heart rate increased to 60/min. How does atropine increase heart rate in bradycardia?<p><img src=\"https://d2enu63wt1sf3u.cloudfront.net/ckfinder/files/10(234).jpg\" alt=\"Question Image\"></p>",
      "unique_key": "Q4228605",
      "question_audio": null,
      "question_video": null,
      "map_id": 34640831,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (B) Increases the rate of IF or “Funny” sodium channels. Atropine increases heart rate in bradycardia by blocking the parasympathetic (vagal) influence on the sinoatrial (SA) node. Parasympathetic activity typically slows the heart by increasing potassium efflux and reducing the activation of “funny” sodium (IF) channels, which are responsible for initiating the slow depolarization (phase 4) in pacemaker cells. By inhibiting muscarinic acetylcholine receptors, atropine reduces vagal stimulation, allowing the “funny” sodium channels to activate more readily. This increases the rate of depolarization in SA node cells, speeding up the pacemaker activity and ultimately raising the heart rate. Reasons for Incorrect Options: A. Decreases potassium efflux: Atropine does not directly affect potassium efflux in pacemaker cells. While parasympathetic stimulation (via acetylcholine) enhances potassium efflux, atropine’s primary action is on muscarinic receptors, indirectly affecting potassium efflux by reducing parasympathetic influence. The main mechanism for the heart rate increase is the enhanced activation of IF sodium channels, not a direct inhibition of potassium efflux. C. Prolongs phase-2 calcium entry: Phase 2 of the cardiac action potential (plateau phase) is primarily significant in ventricular myocytes and involves calcium influx that contributes to contraction. This phase does not play a significant role in SA node pacemaker activity. Atropine does not prolong calcium entry during this phase; instead, its effect is centered on the SA node by modulating phase 4 depolarization. D. Increases the velocity in Purkinje fibers: Purkinje fibers are part of the ventricular conduction system and are not involved in setting the heart rate, which is governed by the SA node. Atropine primarily affects the SA node to increase heart rate and has no direct effect on conduction velocity in Purkinje fibers. Increased heart rate with atropine occurs due to enhanced depolarization of the pacemaker cells rather than changes in Purkinje fiber conduction.",
      "correct_choice_id": 228680,
      "solution_audio": null,
      "solution_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/63884131705729611/63884131705729611.m3u8",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/63884131705729611/63884131705729611.m3u8",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 96659,
      "choices": [
        {
          "id": 228683,
          "text": "Repeat atropine"
        },
        {
          "id": 228684,
          "text": "Start nor-epinephrine"
        },
        {
          "id": 228685,
          "text": "One more vac of NS"
        },
        {
          "id": 228686,
          "text": "Transcutaneous pacemaker"
        }
      ],
      "text": "A 50 year old male diagnosed as inferior wall MI with RVMI developed bradycardia with heart rate of 40/minute. BP- 70/40 mmHg with neck vein distension. Chest is clear on auscultation.CVS-RVS3 noted. ECG shows third degree AV block as suggested by wide QRS and QRS independent of P waves. You immediately give aspirin, started IV fluid normal saline and IV atropine. The pulse rate increases from 40 to 50 beats/minute; BP rises from 70/40 to 84/50 mm Hg. You give an addition stat dose of atropine and another bolus of NS. The pulse rate is now 55 beats/minute and BP is 86/60 mm Hg. What will you do next",
      "unique_key": "Q8884429",
      "question_audio": null,
      "question_video": null,
      "map_id": 34654607,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (D) Transcutaneous pacemaker. This patient has a third-degree (complete) AV block in the context of an inferior wall myocardial infarction (MI) with right ventricular (RV) involvement. Despite initial stabilization measures such as IV fluids and atropine, the patient's bradycardia persists (pulse rate is still significantly below normal at 55 beats/min), and his blood pressure remains critically low (86/60 mm Hg). These findings indicate that atropine alone is insufficient to stabilize the patient. A transcutaneous pacemaker is the next appropriate step to address the hemodynamically significant bradycardia, ensuring adequate cardiac output and perfusion until more definitive measures (such as a transvenous pacemaker) can be implemented if necessary. Transcutaneous pacing is a non-invasive, readily available intervention that can quickly restore an effective heart rate in patients with symptomatic, persistent bradycardia due to AV block. Reasons for Incorrect Options: A. Repeat atropine: Atropine is the first-line treatment for bradycardia caused by increased vagal tone or a reversible block of the SA node or AV node. However, its efficacy in third-degree AV block is limited, as the block is typically distal to the AV node and not vagally mediated. This patient has already received atropine, with only minimal improvement in heart rate and blood pressure. Repeating atropine is unlikely to provide significant benefit in this scenario. B. Start norepinephrine: Norepinephrine can increase systemic vascular resistance and improve blood pressure, but it does not address the underlying bradycardia or conduction block. In this case, the primary issue is insufficient cardiac output due to the low heart rate. Without correcting the bradycardia, relying solely on vasopressors may worsen myocardial ischemia and lead to arrhythmias. C. One more bolus of NS: While fluid resuscitation is appropriate in RVMI to maintain preload, the patient has already received a bolus of normal saline, with only modest improvement in blood pressure. Continued fluid administration alone is unlikely to resolve the bradycardia or significantly improve cardiac output. Overloading with fluids may also risk pulmonary congestion once left ventricular function is impaired.",
      "correct_choice_id": 228686,
      "solution_audio": null,
      "solution_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/24864451705729630/24864451705729630.m3u8",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/24864451705729630/24864451705729630.m3u8",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 96660,
      "choices": [
        {
          "id": 228687,
          "text": "Urgent surgical consultation"
        },
        {
          "id": 228688,
          "text": "Nuclear stress testing to evaluate for ongoing ischemia"
        },
        {
          "id": 228689,
          "text": "Urgent coronary angiography with planned percutaneous coronary intervention"
        },
        {
          "id": 228690,
          "text": "Initiate long-term management with aspirin, angiotensinconverting enzyme (ACE) inhibitor, and beta blocker therapies"
        }
      ],
      "text": "A 68-year-old woman with a history of diabetes and cigarette smoking and previously normal cardiac examination is admitted to the hospital with the new onset of shortness of breath with exertion and orthopnea. She describes having experienced pain in her anterior chest 10 days earlier that lasted several hours and has not recurred. Her blood pressure is 110/88 mm Hg, the heart rate is 102 beats/ min, and she is afebrile. Her examination reveals an elevated jugular venous pressure (JVP), bibasilar crackles, and 1+ pitting edema of both ankles. On auscultation, there is a II/VI early systolic murmur between the left sternal border and apex. The ECG reveals sinus tachycardia with inferior Q waves that were not present on a tracing 6 months earlier. The chest x-ray is consistent with pulmonary edema. She is admitted to the hospital and a transthoracic echocardiogram reveals a left ventricular ejection fraction of 60% with inferior wall hypokinesis with mitral regurgitation. A diuretic is administered. Which of the following is the next most reasonable approach in her management?",
      "unique_key": "Q8935517",
      "question_audio": null,
      "question_video": null,
      "map_id": 34959032,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (A) Urgent surgical consultation. This patient is presenting with heart failure symptoms, including orthopnea, shortness of breath on exertion, jugular venous distension (JVD), bilateral crackles, and pitting edema, alongside an ECG showing inferior Q waves (which suggest a past myocardial infarction). Additionally, the transthoracic echocardiogram reveals left ventricular ejection fraction of 60% (normal range), but with inferior wall hypokinesis and mitral regurgitation. The combination of these findings strongly suggests that this patient has experienced an inferior wall myocardial infarction (MI), which has led to mitral regurgitation and heart failure. Given the acute nature of her presentation, the mitral regurgitation, and the history of chest pain (suggestive of a past ischemic event), it is likely that structural damage to the heart valves or coronary arteries is playing a role in her current condition. The most appropriate next step is an urgent surgical consultation. This is because the patient's mitral regurgitation and heart failure symptoms require immediate evaluation for possible surgical intervention (e.g., mitral valve repair/replacement or revascularization procedures), especially if the MR is due to papillary muscle dysfunction or damage from a previous infarct. Reasons for Incorrect Options: B. Nuclear stress testing to evaluate for ongoing ischemia: This option is incorrect because while this patient has a history of chest pain and signs of ischemia (inferior Q waves on ECG), the priority here is stabilizing her heart failure symptoms. Nuclear stress testing is used to evaluate ongoing ischemia and coronary artery disease but is not the next immediate step in the management of acute heart failure with mitral regurgitation. Given her acute symptoms of heart failure, the focus should be on management of the heart failure and assessing if any surgical intervention is required for the mitral valve or coronary artery. C. Urgent coronary angiography with planned percutaneous coronary intervention: While coronary angiography and percutaneous coronary intervention (PCI) may be appropriate in some cases of acute coronary syndrome (ACS), this patient’s symptoms and inferior Q waves suggest that she may have had a previous MI rather than an acute ischemic event. The patient's current problem is more related to heart failure and mitral regurgitation from a previous infarct. Given that her ejection fraction is preserved and the main concern is mitral regurgitation, the next step is to address the valve problem surgically, rather than intervening on coronary arteries that may no longer be acutely involved. D. Initiate long-term management with aspirin, angiotensin-converting enzyme (ACE) inhibitor, and beta blocker therapies: This option is incorrect because while these therapies are important in chronic heart failure and post-myocardial infarction management, the immediate issue in this patient is severe heart failure symptoms, likely due to mitral regurgitation from left ventricular dysfunction after an infarction. Urgent surgical consultation is needed to evaluate the structural damage to the mitral valve or heart muscle, as this may require surgical intervention before focusing on long-term pharmacologic management. Therefore, the focus should be on urgent surgical evaluation rather than just initiating long-term therapies at this stage.",
      "correct_choice_id": 228687,
      "solution_audio": null,
      "solution_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/45374091705729898/45374091705729898.m3u8",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/45374091705729898/45374091705729898.m3u8",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 96661,
      "choices": [
        {
          "id": 228691,
          "text": "It is inherited as an autosomal dominant condition"
        },
        {
          "id": 228692,
          "text": "Cardiac involvement results in a mixed dilated and restrictive cardiomyopathy"
        },
        {
          "id": 228693,
          "text": "Ventricular hypertrophy with increased QRS voltages is the most common electrocardiographic finding"
        },
        {
          "id": 228694,
          "text": "Mainstay of treatment is iron chelating agents"
        }
      ],
      "text": "A 40-year-old man presents to his physician with shortness of breath on exertion, peripheral edema, and arthritis of his hands. On examination, his vital signs are normal. His sclerae are icteric and his skin has a bronze pigmentation. Lung examination demonstrates rales at the bases; the carotids are of normal upstroke. The cardiac impulse is displaced laterally and there is an audible S3. His abdomen is distended, with evidence of hepatosplenomegaly and ascites. There is peripheral pitting edema. Laboratory studies reveal a serum glucose level of 225 mg/dL and a transferrin saturation of 70%. Which of the following statements about this condition is TRUE?",
      "unique_key": "Q5436491",
      "question_audio": null,
      "question_video": null,
      "map_id": 34195634,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (B) This patient has hemochromatosis due to abnormal deposition of iron in tissues. The most common form of hemochromatosis is inherited as an autosomal recessive disorder due to a mutation in the HFE gene that codes for a transmembrane protein responsible for regulating iron uptake in the intestine and liver. A classic presentation therefore is that of “bronze diabetes” due to excess iron deposition in the dermis and pancreas. Other findings include hypogonadism (impaired hypothalamic-pituitary function), arthropathy (often the small joints of the hands), and cirrhosis. The severity of cardiac involvement in hemochromatosis varies widely and may culminate in heart failure due to a mixed dilated and restrictive cardiomyopathy. Electrocardiographic findings may include supraventricular arrhythmias, varying degrees of atrioventricular block, and low QRS voltage. Diagnosis is based on the history, an elevated plasma iron level, normal or low total iron-binding capacity (TIBC), and markedly increased transferrin saturation (iron: TIBC ratio) and serum ferritin levels. Treatment options include phlebotomy as iron chelating agents are not effective.",
      "correct_choice_id": 228692,
      "solution_audio": null,
      "solution_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/3342611705730137/3342611705730137.m3u8",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/3342611705730137/3342611705730137.m3u8",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 96662,
      "choices": [
        {
          "id": 228695,
          "text": "Hysterical fainting"
        },
        {
          "id": 228696,
          "text": "High-degree atrioventricular block"
        },
        {
          "id": 228697,
          "text": "Epilepsy"
        },
        {
          "id": 228698,
          "text": "Neurocardiogenic syncope"
        }
      ],
      "text": "A 73-year-old woman with recent episodes of dizziness begins to feel lightheaded while seated at church, then within seconds turns pale and slumps to the floor with a few clonic jerks. She regains consciousness 1 minute later, completely aware of where she is and asks what has happened. When an ambulance arrives, her blood pressure is 108/70 mm Hg and the heart rate is 60 beats/min, What is the likely cause of her syncope",
      "unique_key": "Q3631304",
      "question_audio": null,
      "question_video": null,
      "map_id": 34372556,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (B) Cardiac syncope is usually of rapid onset and is not preceded by an aura. Patients typically regain consciousness promptly with a clear sensorium. In any patient with a history of coronary artery disease (CAD), cardiac causes of syncope should be carefully investigated, even when the presenting history is somewhat atypical. Neurologic syncope is sometimes preceded by an aura, is more characteristically associated with incontinence and tongue biting, and is notable for a clouded sensorium with slow clearing after return of consciousness. Seizure-like activity may occur at any time cerebral perfusion is impaired and is not particularly helpful in distinguishing different types of syncope. Distinguishing cardiac syncope due to tachyarrhythmias (usually ventricular tachycardia) from that due to bradyarrhythmias can be difficult on clinical grounds alone. A neurocardiogenic (vasovagal) cause accounts for approximately 50% of syncopal episodes. It may be precipitated by emotional distress, fear, pain, or extreme fatigue or may occur in the setting of diminished venous return with a reduced stroke volume. Hysterical fainting is typically not accompanied by a change in pulse, blood pressure, or skin color. It is often associated with paresthesias of the hands or face, hyperventilation, dyspnea, and other manifestations of acute anxiety.",
      "correct_choice_id": 228696,
      "solution_audio": null,
      "solution_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/65649411705730212/65649411705730212.m3u8",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/65649411705730212/65649411705730212.m3u8",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 96663,
      "choices": [
        {
          "id": 228699,
          "text": "Greater benefit if given in patients with QRS duration <130 msec."
        },
        {
          "id": 228700,
          "text": "A patient with right bundle branch block is as likely to respond to CRT as a patient with left bundle branch block and similar QRS duration"
        },
        {
          "id": 228701,
          "text": "CRT improves myocardial performance without increasing myocardial oxygen consumption"
        },
        {
          "id": 228702,
          "text": "All"
        }
      ],
      "text": "A 56-year-old man with ischemic cardiomyopathy and a left ventricular ejection fraction of 25% comes for an outpatient clinic visit complaining of dyspnea and fatigue with minimal exertion (New York Heart Association class III). His medical regimen includes lisinopril, carvedilol, eplerenone, and furosemide, as well as aspirin and atorvastatin. Resting electrocardiography reveals sinus rhythm with a QRS complex duration of 160 milliseconds and left bundle branch morphology. He is being considered for implantation of a biventricular pacemaker. Which of the following statements about cardiac resynchronization therapy is correct?",
      "unique_key": "Q9956604",
      "question_audio": null,
      "question_video": null,
      "map_id": 34388057,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (C) Cardiac resynchronization therapy (CRT), also known as biventricular pacing, serves to better coordinate left ventricular (LV) contraction, leading to improved ventricular performance and reduced LV filling pressures. CRT improves ventricular function without increasing myocardial energy consumption, in contrast to the effects of inotropic agents such as dobutamine. CRT may also reverse LV remodeling over time, reducing LV mass and end-diastolic dimension while increasing the ejection fraction. CRT reduces mortality in patients with classes III and IV heart failure, left ventricular ejection fraction ?35%, and ventricular dyssynchrony. The greatest benefit of CRT appears to accrue to patients with QRS widening >150 milliseconds and left bundle branch block morphology, compared with those with lesser QRS widening or with right bundle branch block or nonspecific intraventricular conduction delay.",
      "correct_choice_id": 228701,
      "solution_audio": null,
      "solution_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/705101705730242/705101705730242.m3u8",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/705101705730242/705101705730242.m3u8",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 96664,
      "choices": [
        {
          "id": 228703,
          "text": "Increase metoprolol"
        },
        {
          "id": 228704,
          "text": "Add ivabradine"
        },
        {
          "id": 228705,
          "text": "Cardiac resynchronization therapy"
        },
        {
          "id": 228706,
          "text": "No changes to the regimen as patient is stable"
        }
      ],
      "text": "A 35-year-old woman with peripartum cardiomyopathy, left ventricular ejection fraction 25%, and a dual chamber implantable cardioverter-defibrillator (ICD) comes to see you for a routine clinic evaluation. She is able to perform most of her daily activities without limitation, but becomes short of breath walking one flight of stairs. She is currently treated with metoprolol 50 mg daily, telmisartan 80 mg daily, furosemide 40 mg daily, and spironolactone 25 mg daily. On examination the heart rate is 84 beats/min, blood pressure 110/70 mm Hg, jugular venous pressure 7 cm, the lungs are clear to auscultation, and there is no peripheral edema. The electrocardiogram shows sinus rhythm with right bundle branch block and QRS duration of 120 ms. Which of the following is the most appropriate next step in her heart failure management?",
      "unique_key": "Q8733706",
      "question_audio": null,
      "question_video": null,
      "map_id": 34025779,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (A) This patient has heart failure with reduced ejection fraction and New York Heart Association (NYHA) II symptomatology on a pharmacologic regimen that includes a beta blocker, angiotensin receptor blocker, and mineralocorticoid receptor antagonist. Although she has only mild heart failure symptoms, treatment guidelines recommend further medical optimization for additional clinical benefit. Her heart rate is 84 beats/min in sinus rhythm, and the beta blocker dosage is below guideline-recommended targets (i.e., up to 200 mg daily for metoprolol). The appropriate next step is therefore to upwardly titrate the beta blocker. If she does not tolerate augmentation of the beta blocker, then consideration of the If channel inhibitor, ivabradine, would be appropriate for heart rate reduction. Cardiac resynchronization therapy is indicated with LVEF ?35% who are in sinus rhythm with left bundle branch block and QRS duration ?130 milliseconds, and would be less beneficial for this patient with right bundle branch block and QRS duration of 120 milliseconds.",
      "correct_choice_id": 228703,
      "solution_audio": null,
      "solution_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/40846491705730257/40846491705730257.m3u8",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/40846491705730257/40846491705730257.m3u8",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 96665,
      "choices": [
        {
          "id": 228707,
          "text": "Digoxin"
        },
        {
          "id": 228708,
          "text": "Perindopril"
        },
        {
          "id": 228709,
          "text": "Spironolactone"
        },
        {
          "id": 228710,
          "text": "None of the above"
        }
      ],
      "text": "A 68-year-old woman with long-standing hypertension presents to the emergency department because of progressive exertional dyspnea and fatigue over the past several months. Her medications include atenolol and hydrochlorothiazide. On examination, she is an overweight woman with heart rate of 70 beats/min, respiratory rate of 20 breaths/min, and blood pressure of 170/90 mm Hg. The jugular venous pressure is 14 cm. Examination of the chest is notable for bibasilar rales. The cardiovascular examination reveals a normal S1, physiologically split S2, and S4 gallop. There is no audible murmur. The extremities demonstrate pitting edema to the midcalf bilaterally. The ECG reveals sinus rhythm with voltage criteria for left ventricular (LV) hypertrophy. The chest radiograph shows a normal cardiac silhouette with bilateral pleural effusions with mild interstitial pulmonary edema. Echocardiography demonstrates concentric LV hypertrophy. The estimated ejection fraction is 70%. Which of the following pharmacologic agents has been shown to consistently improve survival in this condition?",
      "unique_key": "Q4710285",
      "question_audio": null,
      "question_video": null,
      "map_id": 34860900,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (D) None of the above. This patient presents with progressive exertional dyspnea, fatigue, pitting edema, bibasilar rales, elevated jugular venous pressure, and concentric left ventricular (LV) hypertrophy on echocardiography, all of which are consistent with diastolic heart failure (also known as heart failure with preserved ejection fraction or HFpEF). Despite having normal ejection fraction (EF) (70%), the patient demonstrates signs of heart failure, with increased filling pressures due to diastolic dysfunction. Currently, there is no pharmacologic agent that has been definitively shown to improve survival in patients with HFpEF, unlike in systolic heart failure (HFrEF) where treatments such as ACE inhibitors, beta blockers, and spironolactone have proven survival benefits. Therefore, the correct answer is D. None of the above because digoxin, perindopril, and spironolactone have not been shown to consistently improve survival in HFpEF. Reasons for Incorrect Responses: A. Digoxin: This is incorrect. Digoxin is primarily used for rate control in atrial fibrillation and for symptom management in heart failure, but it does not improve survival in either HFpEF or HFrEF. While it can help with symptom relief, it does not provide the same mortality benefit seen with other heart failure treatments like ACE inhibitors or beta blockers in HFrEF. B. Perindopril: This is incorrect. ACE inhibitors like perindopril are well-established in heart failure with reduced ejection fraction (HFrEF) for improving survival and symptoms. However, their benefit in HFpEF is much less clear. Although they may help with symptom control (such as reducing blood pressure and alleviating some fluid retention), ACE inhibitors do not have consistent evidence to show improved survival in patients with HFpEF. Therefore, perindopril is not a definitive answer to improve survival in this patient. C. Spironolactone: This is incorrect. Spironolactone is an aldosterone antagonist that has been shown to improve survival in HFrEF. However, in HFpEF, while it may help with fluid retention, it has not been consistently shown to improve survival. The TOPCAT trial, which studied the use of spironolactone in HFpEF, did not demonstrate a significant reduction in mortality. Therefore, it is not the correct choice in this scenario for improving survival in HFpEF.",
      "correct_choice_id": 228710,
      "solution_audio": null,
      "solution_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/2893601705730287/2893601705730287.m3u8",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/2893601705730287/2893601705730287.m3u8",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 96666,
      "choices": [
        {
          "id": 228711,
          "text": "Cardiac resynchronization therapy"
        },
        {
          "id": 228712,
          "text": "Urgent listing for cardiac transplantation"
        },
        {
          "id": 228713,
          "text": "Listing for combined heart-kidney transplantation"
        },
        {
          "id": 228714,
          "text": "Implantation of a left ventricular assist device"
        }
      ],
      "text": "A 72-year-old diabetic man with long-standing dilated cardiomyopathy presents for evaluation of dyspnea at rest. He has been hospitalized three times within the past year for decompensated heart failure and recently underwent a cardiopulmonary exercise test showing a peak oxygen consumption of 10 mL/kg/min during maximal effort. His past medical history is notable for prior placement of an implantable cardioverter-defibrillator for primary prevention of sudden cardiac death, and prostatectomy 1 year earlier for adenocarcinoma. For the past 6 months he has been intolerant of beta-adrenergic blockers because of hypotension. He has a supportive family, adheres to therapeutic recommendations, and does not use tobacco. Physical examination reveals a blood pressure of 92/78 mm Hg, resting heart rate of 106 beats/min, body mass index of 26 kg/m2 , jugular venous pressure of 10 cm H2O, clear lungs, an S3 apical gallop, and cool extremities but no evidence of hepatomegaly or ascites. Laboratory studies are notable for the following: sodium 126 mEq/L; potassium 4.6 mEq/L; blood urea nitrogen 34 mg/dL; and creatinine 2.5 mg/dL. Liver function tests and the complete blood cell count are normal. Electrocardiography shows sinus tachycardia and a QRS complex duration of 96 milliseconds. Echocardiography demonstrates a dilated left ventricle with an ejection fraction of 20%, mild mitral regurgitation, and normal right ventricular size and function. Which of the following is the most appropriate consideration for this patient?",
      "unique_key": "Q8782878",
      "question_audio": null,
      "question_video": null,
      "map_id": 34774079,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (D) Implantation of a left ventricular assist device (LVAD). This 72-year-old diabetic man with long-standing dilated cardiomyopathy and severe heart failure is experiencing progressive dyspnea at rest and has a very low peak oxygen consumption (10 mL/kg/min), indicating severe functional limitation. He also has intolerance to beta-blockers, hyponatremia, renal dysfunction, and an ejection fraction of 20%, which are all signs of end-stage heart failure. Given his frequent hospitalizations for decompensated heart failure and failure to respond to standard therapies, an implantable left ventricular assist device (LVAD) is the most appropriate consideration. An LVAD can provide circulatory support, improve symptoms, and increase survival by helping the heart pump more effectively in patients with end-stage heart failure who are not candidates for heart transplantation. Reasons for Incorrect Responses: A. Cardiac resynchronization therapy (CRT): This is incorrect. Cardiac resynchronization therapy (CRT) is useful for patients with heart failure, left ventricular dysfunction, and interventricular conduction delays, particularly those with a QRS duration of ≥150 milliseconds and symptomatic heart failure. However, this patient has a QRS duration of 96 milliseconds, which does not meet the threshold for CRT. Additionally, CRT is typically used in patients with moderate to severe heart failure but is unlikely to be sufficient for this patient who has severe, end-stage heart failure with an ejection fraction of 20% and ongoing symptoms despite maximal medical therapy. B. Urgent listing for cardiac transplantation: This is incorrect. Although heart transplantation is an option for patients with end-stage heart failure, this patient has renal dysfunction (creatinine of 2.5 mg/dL) and hyponatremia (sodium of 126 mEq/L), both of which are contraindications to immediate listing for heart transplantation. These complications need to be stabilized before he would be considered for listing. Therefore, LVAD implantation is a more appropriate next step as it can help stabilize the patient while he is evaluated for heart transplantation. C. Listing for combined heart-kidney transplantation: This is incorrect. While this patient has both heart failure and renal dysfunction, the presence of mild kidney dysfunction (elevated creatinine but not at end-stage renal failure) does not meet the criteria for combined heart-kidney transplantation. Patients are typically considered for combined heart-kidney transplantation when they have end-stage heart failure and advanced kidney disease (e.g., requiring dialysis). In this patient, the focus should be on improving heart function and renal perfusion through LVAD implantation before considering combined transplantation.",
      "correct_choice_id": 228714,
      "solution_audio": null,
      "solution_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/2038521705730328/2038521705730328.m3u8",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/2038521705730328/2038521705730328.m3u8",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 96667,
      "choices": [
        {
          "id": 228715,
          "text": "The presenting stroke is an indication for urgent valve replacement"
        },
        {
          "id": 228716,
          "text": "Endocarditis caused by S. aureus is an absolute indication for surgery"
        },
        {
          "id": 228717,
          "text": "Despite the aggressiveness of S. aureus native valve endocarditis, antibiotic therapy alone without surgical intervention is often curative"
        },
        {
          "id": 228718,
          "text": "Even if intractable heart failure develops, corrective valve surgery should be postponed until after blood cultures have become sterile"
        }
      ],
      "text": "A 76-year-old man presents to the emergency department with aphasia and dense right hemiplegia. His wife reports that he had experienced intermittent fevers and chills over the previous 2 weeks. Cardiac examination is notable for a grade 2/6 systolic ejection murmur at the upper right sternal border and grade 1/4 early diastolic murmur at the upper left sternal border. Four sets of blood cultures grow Staphylococcus aureus. A transthoracic echocardiogram demonstrates normal left ventricular contractile function and mild aortic stenosis. No vegetations are seen. Computed tomography of the head shows an acute non hemorrhagic stroke in the territory of the left middle cerebral artery. Which of the following statements is TRUE?",
      "unique_key": "Q5723102",
      "question_audio": null,
      "question_video": null,
      "map_id": 34395679,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (C) Despite the aggressiveness of S. aureus native valve endocarditis, antibiotic therapy alone without surgical intervention is often curative. This patient presents with infective endocarditis (IE) caused by Staphylococcus aureus, a highly virulent pathogen. Staphylococcus aureus endocarditis can be aggressive, but antibiotic therapy alone can sometimes be sufficient in cases of native valve endocarditis without significant complications, especially in patients who are not experiencing severe heart failure or other complications that would require surgical intervention. Although surgery may be necessary in certain cases (e.g., large vegetations, persistent infection, heart failure), many patients with S. aureus endocarditis can achieve cure with appropriate antibiotics, particularly if there are no major indications for surgery like valvular destruction, large vegetations, or heart failure that is not responsive to medical management. Incorrect Responses: A. The presenting stroke is an indication for urgent valve replacement This option is incorrect. While stroke is a common complication of infective endocarditis, it does not necessarily require urgent valve replacement. In fact, management typically focuses on treating the infection with appropriate antibiotics and addressing any immediate complications like stroke or heart failure. Urgent valve surgery is usually reserved for cases with severe valvular dysfunction, large vegetations, or persistent infection despite antibiotic therapy. Stroke alone, especially without severe valve damage or other urgent complications, does not mandate urgent valve surgery. B. Endocarditis caused by S. aureus is an absolute indication for surgery This option is incorrect. Although S. aureus is a highly virulent organism, causing a more aggressive form of infective endocarditis, it is not an absolute indication for surgery in all cases. Surgical intervention is indicated in cases of severe valvular dysfunction, persistent infection despite adequate antibiotic therapy, heart failure, or large vegetations. Not all patients with S. aureus endocarditis require surgery, and many can be successfully managed with antibiotics alone, especially when the valve is not severely damaged. D. Even if intractable heart failure develops, corrective valve surgery should be postponed until after blood cultures have become sterile This option is incorrect. In the case of intractable heart failure due to infective endocarditis, corrective valve surgery may be necessary even before blood cultures have become sterile. Surgery may be required to prevent further cardiac damage and to address severe heart failure that cannot be controlled with medical therapy alone. While sterilization of blood cultures is an important goal of antibiotic therapy, it is not always required before performing surgery, especially if the patient is experiencing severe heart failure or other life-threatening complications. Immediate surgical intervention can be critical in such cases.",
      "correct_choice_id": 228717,
      "solution_audio": null,
      "solution_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/72100041705730938/72100041705730938.m3u8",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/72100041705730938/72100041705730938.m3u8",
      "question_images": [],
      "explanation_images": []
    }
  ]
}